USANA Chief Financial Officer Doug Hekking was honored by Utah Business Magazine CXO with the CXO of the Year Award.

USANA released its 2022 Sustainability Report, highlighting advancements made toward the ESG initiatives it began evaluating in 2020, including a 20% reduction in waste sent to landfills, 50% renewable energy usage at the company’s Salt Lake campus, the saving of the equivalent of 435,266 plastic bottles by moving to smaller packaging and an $11.6 million investment in research and development. 

With a focus on positive business practices, USANA recently released its annual sustainability report.  The USANA 2022 sustainability report highlights the company's recent Environmental, Social, and Governance (ESG) achievements.

USANA Health Sciences, Inc. released its financial results for the first fiscal quarter, posting net sales of $248 million, a 9% sequential increase from $228 million in the fourth quarter of 2022, but a net sales decline from the first quarter of 2022, which totaled $273 million.

USANA Health Sciences, Inc. released its financial report for Q4 and full year fiscal 2022.

Rise Bar manufactures high-quality protein bars with clean and simple ingredients while Oola is an emerging direct selling company that focuses on helping customers design a personal development framework that creates balance, growth and purpose.

USANA Health Sciences, Inc. reported third quarter net sales of $233 million, representing a 15% decline from last year’s $274 million during the same time period.

For more than 30 years, CEO Kevin Guest has had a front row seat for USANA’s steady growth and commitment to innovation. As he and the company celebrate three decades in business, the team is more excited about what lies ahead for USANA, the possibilities on the horizon and a growing global presence.

As part of its own call to action, USANA reached its humanitarian goal of funding 30,000 Garden Towers, a self-sustaining method for planting multiple food crops that utilize large mesh bags filled with soil.

USANA Health Sciences, Inc. announced its financial results for the second quarter of 2022, including a 14% decline in active customers from the previous year’s quarter, totaling 559,000.

USANA Health Sciences, Inc. announced its preliminary financial results for the second quarter of 2022, including net sales of $265 million, down from $337 million during the same quarter last year. Earnings per share expectations were also down at $1.05, compared to $1.87 during the second quarter of 2022. 

The multi-day educational event offered new insight and strategies for connecting with a rapidly evolving market.